The unfolded protein response and its activation by insulin in muscle are not altered by obesity or type 2 diabetes
Clinical Science · 10.06.2026 · 140 (6) · 961-973
DOI: 10.1042/cs20250639 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Science, online erschienen am 18.05.2026. Verfasst von Rikke Kruse und 6 weiteren Autor:innen. Beteiligte Einrichtung: Steno Diabetes Center Odense, Odense University Hospital, DK-5000 Odense C, Denmark. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Unfolded Protein Response, Insulin, Muscle, Skeletal. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Danish Council for Independent Research, Novo Nordisk Foundation.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Insulin resistance in obesity and type 2 diabetes (T2D) is characterized by reduced insulin-stimulated glucose uptake, accumulation of triacylglycerol, mitochondrial dysfunction, and altered protein metabolism in skeletal muscle. This may involve disturbed endoplasmic reticulum (ER) homeostasis, leading to alterations in the unfolded protein response (UPR) and, hence, the protein folding capacity. Here, we investigated whether markers of UPR activity are elevated in skeletal muscle in obesity and T2D and to what extent insulin regulates these UPR markers. In a case–control design, we determined mRNA expression, protein abundance, and phosphorylation of key UPR markers in skeletal muscle biopsies obtained from patients with T2D, matched to glucose-tolerant individuals with obesity and lean individuals, before and after 4-h insulin infusion during a hyperinsulinemic-euglycemic clamp. The mRNA expression or protein abundance of GRP78, the canonical ER stress sensors (ATF6, PERK, and IRE-1α), several downstream UPR markers, and related markers of mitochondrial dynamics did not differ between groups. Insulin increased the mRNA expression of ATF6, ERN1 (encoding IRE-1α), XBP1, DDIT3 (encoding CHOP), and a marker of mitochondrial fission, DNM1l (encoding DRP1), as well as eIF2α Ser51 phosphorylation in skeletal muscle in all groups (all P <0.05), with no between-group differences. Our results demonstrate that markers of UPR activity are not elevated in skeletal muscle in obesity or T2D. Interestingly, insulin increases the expression of UPR markers and activates eIF2α, which is necessary for increasing the protein folding capacity of ER in muscle, and these responses are intact in obesity and T2D.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Steno Diabetes Center Odense, Odense University Hospital, DK-5000 Odense C, Denmark.
- Department of Clinical Research, University of Southern Denmark, DK-5230 Odense M, Denmark.
- The August Krogh Section for Molecular Physiology, Department of Nutrition, Exercise, and Sports, University of Copenhagen, DK-2100 Copenhagen, Denmark.
ORCID-Profile: Rikke Kruse, Jonas Møller Kristensen, Jacob Volmer Stidsen, Rugivan Sabaratnam, Kurt Højlund
Förderung
- Danish Council for Independent Research
- Novo Nordisk Foundation
Zitieren
APA
Kruse, R., Kristensen, J. M., Vind, B. F., Juhl, S., Stidsen, J. V., Sabaratnam, R., & Højlund, K. (2026). The unfolded protein response and its activation by insulin in muscle are not altered by obesity or type 2 diabetes. Clinical Science, 140(6), 961-973. https://doi.org/10.1042/cs20250639
Vancouver
Kruse R, Kristensen JM, Vind BF, Juhl S, Stidsen JV, Sabaratnam R, et al. The unfolded protein response and its activation by insulin in muscle are not altered by obesity or type 2 diabetes. Clinical Science. 2026;140(6):961-973. doi:10.1042/cs20250639
BibTeX
@article{Kruse2026,
author = {Kruse, Rikke and Kristensen, Jonas Møller and Vind, Birgitte Falbe and Juhl, Stine and Stidsen, Jacob Volmer and Sabaratnam, Rugivan and Højlund, Kurt},
title = {The unfolded protein response and its activation by insulin in muscle are not altered by obesity or type 2 diabetes},
journal = {Clinical Science},
year = {2026},
volume = {140},
number = {6},
pages = {961--973},
doi = {10.1042/cs20250639}
}
EUVIMED